Ariosa Diagnostics, Inc. Release: American College of Medical Genetics Supports Non-invasive Prenatal Screening for Fetal Aneuploidy Detection in Pregnant Women
4/8/2013 9:57:27 AM
More...
|
Ariosa Diagnostics, Inc. Release: New Studies Highlight Obstetrician Experiences and Attitudes Toward Adoption of Non-Invasive Prenatal Testing in the Practice Setting
4/2/2013 10:09:15 AM
More...
|
Ariosa Diagnostics, Inc. Introduces Y-Chromosome Analysis Test Option
3/18/2013 10:38:06 AM
More...
|
Ariosa Diagnostics, Inc. Welcomes New Board Member Michael A. Aicher
2/25/2013 8:55:02 AM
More...
|
Ariosa Diagnostics, Inc. Release: New Study Demonstrates Non-Invasive Prenatal Testing in High-Risk Women at Price Point of $795 is Clinically Beneficial and Cost-Saving to the Healthcare System
1/29/2013 9:43:55 AM
More...
|
Ariosa Diagnostics, Inc. Announces Partnership With The Doctors Laboratory (TDL) to Distribute the Harmony™ Prenatal Test in the UK
1/9/2013 9:35:00 AM
More...
|
Ariosa Diagnostics, Inc. Enters 2013 With New Offering and Global Expansion
1/9/2013 9:32:44 AM
More...
|
Ariosa Diagnostics, Inc. Release: WellPoint Supports Cell-Free Fetal DNA-Based Prenatal Screening for Fetal Aneuploidy in Certain Pregnancies
12/20/2012 10:01:25 AM
More...
|
Ariosa Diagnostics, Inc. to Present at the J.P. Morgan 31st Annual Healthcare Conference
12/19/2012 6:57:49 AM
More...
|
Ariosa Diagnostics, Inc. Release: Clinical Utility of the Harmony™ Prenatal Test in General Screening Population Highlighted During Fetal Medicine Foundation Course
12/4/2012 10:11:40 AM
More...
|
|